Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Incomplete Dominance

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate Cancer.

The Prostate·2026

Same author

Precision oncology platforms: practical strategies for genomic database utilization in cancer treatment.

Molecular cytogenetics·2024

Same author

Multitarget Fluorescence In Situ Hybridization Diagnostic Applications in Tumors.

Methods in molecular biology (Clifton, N.J.)·2024

Same author

Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer.

Molecular cytogenetics·2024

Same author

Investigating the Role of <i>SNAI1</i> and <i>ZEB1</i> Expression in Prostate Cancer Progression and Immune Modulation of the Tumor Microenvironment.

Cancers·2024

Same author

Germline variants in early and late-onset Brazilian prostate cancer patients.

Urologic oncology·2024

Search research articles

Related Experiment Video

Updated: May 21, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

The genetics of osteosarcoma.

Jeff W Martin¹, Jeremy A Squire, Maria Zielenska

¹Department of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada M5G 1X8.

|June 12, 2012

Summary

This summary is machine-generated.

Osteosarcoma, a primary bone cancer in children, has unknown causes due to complex genomic changes. Research identifies common genetic alterations, but specific oncogenes and tumor suppressor genes remain elusive.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Related Experiment Videos

Last Updated: May 21, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Area of Science:

Genetics
Oncology
Genomics

Background:

Osteosarcoma is a primary bone malignancy with a high incidence in children and adolescents.
The exact cause of osteosarcoma is unknown due to complex genomic rearrangements in cancer cells.
Few consistent genetic changes have been identified as potential therapeutic targets.

Purpose of the Study:

To examine studies on osteosarcoma genetics.
To comprehensively describe the heterogeneity and complexity of this cancer.

Main Methods:

Review of existing studies on osteosarcoma genetics.
Analysis of high-resolution genomic data.

Main Results:

Copy number gains detected at chromosomes 1p, 1q, 6p, 8q, and 17p.
Copy number losses detected at chromosomes 3q, 6q, 9, 10, 13, 17p, and 18q.
Definitive oncogenes or tumor suppressor genes remain elusive for many identified loci.

Conclusions:

Osteosarcoma exhibits significant genetic heterogeneity and complexity.
Further research is needed to identify specific genetic targets for molecular therapies.